天宜上佳(688033.SH):董事長吳佩芳不兼任總經理 由吳鵬接任
格隆匯9月7日丨天宜上佳(688033.SH)公佈,鑑於公司發展規模不斷擴大,為更好地履行董事長職責,投入更多精力於公司的整體發展戰略佈局,加強管理團隊建設,提升公司戰略管理水平,公司董事長兼總經理吳佩芳向董事會提交辭職報吿,辭去公司總經理職務。辭職後,吳佩芳仍擔任公司董事長、董事會戰略委員會主任委員、提名委員會委員、審計委員會委員以及薪酬與考核委員會委員的職務。
經公司董事長吳佩芳提名,董事會提名委員會審查,公司第二屆董事會第三十次會議審議通過了《關於聘任公司總經理的議案》,董事會同意聘任吳鵬為公司總經理,任期自本次董事會審議通過之日起至本屆董事會屆滿為止,吳鵬將不再擔任公司副總經理職務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.